DePuy Limb Preservation System Recall Gets FDA’s Highest-Risk Status

The FDA puts its highest-risk Class I label on a fracture risk recall of Johnson & Johnson subsidiary DePuy Orthopaedics’ LPS Lower Extremity Dovetail Intercalary Component



Federal healthcare regulators put their highest-risk Class I label on a recall of Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics’ Limb Preservation System  after the company warned that certain components may fracture and harm patients.


The recall affects 16 lot numbers of the LPS devices, covering those manufactured between February 2007 and May 2013, according to the FDA notice.


In earlier notices, flagged by the Hong Kong Dept. of Health, DePuy warned that the female component of the affected part – called the lower extremity dovetail intercalary component – might break under abnormal force loads. The new warning adds that the devices may break “when exposed to normal physiologic loads while walking.”


The device is especially vulnerable in patients who weigh over 200 lbs, especially during more robust activities like suddenly standing or climbing up and down stairs, according to the Hong Kong report.

Print Friendly, PDF & Email

Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button